Rajesh Singh

Rajesh Singh is a Senior Scientist at Arcus Biosciences since July 2020, leading programs in target characterization and preclinical development within immuno-oncology, as well as managing a cross-functional team for small molecule drug discovery. Previously, Rajesh served as a Scientist, focusing on new immuno-oncology targets and optimizing CRISPR-based gene knockout techniques in primary human T cells. Rajesh's experience includes roles as a Research Scientist and Postdoctoral Fellow at Weill Cornell Medicine, along with a brief Postdoctoral Fellowship at the Ottawa Hospital Research Institute. Rajesh holds a PhD in Molecular Medicine, an MS in Immunology, and a BS in Biochemistry, all from Imperial College London.